Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

Robert J. Fox

Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland

Amit Bar-Or

Center for Neuroinflammation and Experimental Therapeutics, Department of Neurology, University of Pennsylvania, Philadelphia

Anthony Traboulsee

Division of Neurology, University of British Columbia, Vancouver, Canada

Celia Oreja-Guevara

Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid

Gavin Giovannoni

Queen Mary University of London, Blizard Institute, Faculty of Medicine and Dentistry, London

Patrick Vermersch

Sana Syed

Sanofi, Cambridge, MA

Ye Li

Wendy S. Vargas

Sanofi, Bridgewater, NJ

Timothy J. Turner

Sanofi, Cambridge, MA

Erik Wallstroem

Sanofi, Cambridge, MA

Daniel S. Reich